Researchers from Trinity College Dublin have developed a new, machine learning-based technique to accurately classify the state of macrophages, which are key immune cells. Classifying macrophages is important because they can modify their behaviour and act as pro- or anti-inflammatory agents in the immune response. As a result, the work has a suite of implications for research and has the potential to one day make major societal impact.
For example, this new approach could be of use to drug designers looking to create therapies targeting diseases and auto-immune conditions such as diabetes, cancer and rheumatoid arthritis -- all of which are impacted by cellular metabolism and macrophage function.
Because classifying macrophages allows scientists to directly distinguish between macrophage states -- based only on their metabolic response under certain conditions -- this new information could be used as a diagnosis tool, or to highlight the role of a particular cell type in a disease environment.
The landmark research, which used human macrophages in experiments, was led by Michael Monaghan, Associate Professor in Biomedical Engineering at Trinity. The work brought together biomedical engineers, computer scientists and immunologists and has just been published in leading journal eLife. Professor Monaghan comments:
"Currently, there are no other methods that employ artificial intelligence-based, machine learning approaches to macrophage classification. A number of different techniques are currently used to classify macrophages, but all of these have significant drawbacks.
"Our method uses a 2-photon fluorescence lifetime imaging microscope (2P-FLIM), which is unique to Trinity and to Ireland. 2P-FLIM does not require sample pre-treatment, can be used to follow changes in metabolism non-invasively and in real-time -- which opens the door to tracking disease progression and/or physiological response to therapies -- and it also requires a lower number of cells compared with conventional techniques."
Nuno Neto, PhD Candidate in the School of Engineering, added:
"It is becoming increasingly clear that to solve many of society's greatest problems, we need to take multi-disciplinary approaches to harness the expertise of people working in different fields.
"Trinity is rightly known as a leader in immunometabolism research, with many of our scientists focusing on how it regulates immune cell response, and how immune cell metabolism is impacted in diseases. This study benefits from that expertise, but also bridges the use of advanced computer science approaches and utilises an advanced microscope from the Biomedical Engineering Department with a regime never reported previously. It thus serves as a prime example of inter-departmental collaboration in a multidisciplinary field."
Nuno Neto's Doctoral Studies are supported by a Trinity College Dublin Provost's PhD Award and Professor Monaghan is a Funded Investigator in the Science Foundation Ireland (SFI) Centres AMBER and CÚRAM. Trinity's FLIM Core Unit directed by Professor Monaghan was established using an SFI Infrastructure Programme: Category D Opportunistic Funds Call.
Cite This Page: